HIV-1 strains in humans arose from three independent ape-to-human transmissions in the early 20th century, but the viral adaptation in humans remained unknown until now. Paul Sharp and colleagues from ...

Of those surveyed, 34% believe they are unlikely ever to contract HIV, and 20% said they ‘can’t be bothered’ to test for the ...

The NIH has eliminated funding for dozens of HIV-related research grants, according to a US Department of Health and Human ...

People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

Key funding to help lessen the spread of HIV in Austin could be affected as part of the federal Department of Government ...

Lenacapavir blocks HIV from entering and reproducing in human cells, providing long-term protection in a one-time dose. This could be a game-changer for those who struggle with daily pill management.

What about viruses? Would you consider them living or nonliving? Let’s look closely at the life cycle of the human immunodeficiency virus (HIV) – the virus that causes AIDS – to find out. This ...

INSTIs block integrase, an enzyme that HIV uses to put HIV DNA into human DNA inside the CD4 T cells. INSTIs belong to a category of drugs known as integrase inhibitors. INSTIs are well ...

HIV outbreak in Kerala sparks fear and stigma among injecting drug users, prompting urgent response from health authorities.

the South American country recorded a sharp increase in the number of cases of the human immunodeficiency virus (HIV), it was reported in Asunción. The research found 1,519 new HIV diagnoses in ...

First-in-human study evaluating a novel long-acting injectable antiretroviral therapy provides promising early results on its ...